CAU's Principal Activity is the expansion of business to develop and sell ranges of cannabinoid-based and related brands and sell the resulting products in Australia and target export markets, including Japan and Hong Kong, as well as expanding Cannadoc Health Pty. Ltd., its medical clinic business in Australia and New Zealand.
|Bid / Ask||-|
|Volume (4w avg)|
|vs Sector (1yr)||+109.87%|
|vs ASX 200 (1yr)||+91.58%|
|ASX Rank||2,121 of 2,319|
|Sector Rank||184 of 198|
Cronos Australia Limited (CAU) is a company within the Health Care sector listed on the ASX. It plans to enter the medicinal cannabis market in Australia with both THC and CBD products. Cronos Australia is committed to providing Australian patients access to the quality medicinal cannabis products, as well as supplying export markets globally. Cronos Australia has secured all the necessary Australian licences to operate - including import and export licences.
No incorporation details available.
DPS and Yield calculations use the Pay Date.
|Mr Thomas Godfrey Howitt||Chief Financial Officer,Company Secretary||Aug 2020|
|Mr Jason Marc Adler||Non-Executive Director||Apr 2019||
Mr Jason Marc Adler
Mr Adler is a Director of Cronos Group Inc and is a co-founder and Managing Member of Gotham Green Partners ("Gotham Green"). Prior to founding Gotham Green, Jason was the co-founder and Chief Executive Officer of Alphabet Partners, LP. Jason also founded Geronimo, LLC and began his career as a market maker at G&D Trading.
|Mr Michael Ryan Gorenstein||Non-Executive Director||Apr 2019||
Mr Michael Ryan Gorenstein
Mr Gorenstein is the Executive Chairman of Cronos Group Inc. He is also a co-founder and Member of Gotham Green Partners and sits on the Board of Directors of Natuera, Cronos Group's South American joint venture. Before joining the Company, Michael was the Vice President and General Counsel at Alphabet Partners, LP. Prior to Alphabet Partners, LP, he was a corporate attorney at Sullivan & Cromwell LLP where he focused on mergers and acquisitions and capital markets transactions.
|Mr Daniel Ernest Abrahams||Non-Executive Director||Oct 2018||
Mr Daniel Ernest Abrahams
Mr Abrahams is an independent consultant providing entrepreneurship and leadership programs to universities, helping students and alumni take ideas to commercialisation, and acting as an independent adviser to companies on scaling up. Prior to this, Daniel was an Executive Director and Chief Executive Officer of Superloop Limited. Daniel has also held senior executive positions at Aurizon Holdings Limited, Suncorp Group Limited, Energex and Toyota Tsusho South Pacific. He is Chairman of Risk Committee.
|Mr Shane Francis Tanner||Non-Executive Chairman,Non-Executive Director||Oct 2018||
Mr Shane Francis Tanner
Non-Executive Chairman,Non-Executive Director
Mr Tanner was Chairman of Vision Eye Institute, Chief Executive Officer of Mayne Nickless Diagnostic Services (later renamed Symbion Health) and Chief Financial Officer of Mayne Group. Shane has strategy and transaction experience, including whilst working at Mayne Group via the IPO of telecommunications company, Optus Communications. He is Member of Risk Committee.
|Mr Rodney Damon Cocks||Chief Executive Officer,Executive Director||Sep 2018||
Mr Rodney Damon Cocks
Chief Executive Officer,Executive Director
Mr Cocks is a Director of NewSouthern Capital Pty. Ltd. Prior to joining CAL, he was a member of the Senior Leadership Team at Linfox and was a Consultant at the Boston Consulting Group. Rodney served on the Counter Narcotics Team of the British Embassy in Afghanistan and with the United Nations in Afghanistan, Sri Lanka, Pakistan and Iraq and started his career as an Infantry Officer in the Australian Army.
|Ms Anna Elizabeth Burke||Non-Executive Director||Sep 2018||
Ms Anna Elizabeth Burke
Ms Burke served in the Australian Federal Parliament as the Member for Chisholm in the House of Representatives from 1998 to 2016 and was also the 28th Speaker of the Australian House of Representatives. She currently serves as a Member of the Administrative Appeals Tribunal. Anna had Committee service in the Federal Parliament, including serving as a member of the Joint Statutory Committee on Corporations and Financial Services and the House of Representatives Standing Committee on Economic, Finance and Public Administration. Prior to Anna's parliamentary career, she was an Industrial Officer with VicRoads, Victorian University of Technology and the Financial Sector Union. Anna was appointed as an Officer of the Order of Australia in January 2019. She is Member of Risk Committee.
CAU directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
|04/09/20||Anna Burke||Buy||+25,000||$0.089||$2,229||On-market trade|
|08/04/20||Anna Burke||Buy||+50,000||$0.089||$4,429||On-market trade|
|23/03/20||Shane Tanner||Buy||+50,000||$0.085||$4,250||On-market trade|
|18/03/20||Daniel Abrahams||Buy||+100,000||$0.09||$9,000||On-market trade|
|16/03/20||Shane Tanner||Buy||+300,000||$0.09||$26,994||On-market trade|
The current holdings of CAU directors.
|Director||Last Notice||Direct Shares||Indirect Shares||Options||Convertibles|
A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.
Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.
|Name||Last Notice||Total Shares||Shares Held (%)|
|Cronos Global Holdings Inc||27/09/2021||40,000,000||31.07|
|Peter John Righetti||27/09/2021||20,000,000||15.53|
|NewSouthern Investment Holdings 1 Pty Ltd||27/09/2021||20,000,000||15.53|
12 month transaction history compiled from ASX announcements.
No buy transactions reported by Substantial Shareholders in the past 12 months.
12 month transaction history compiled from ASX announcements.
No sell transactions reported by Substantial Shareholders in the past 12 months.
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.